પોલી મેડિક્યોર શેર કિંમત

Healthcare Supplies company Poly Medicure announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: For Q4FY26, Revenue from Operations stood at Rs 53,451.14 lakh, registering a growth of 8.28% QoQ compared to Rs 49,365.55 lakh in Q3FY26, and a strong increase of 21.25% YoY from Rs 44,082.82 lakh in Q4FY25. Annual Revenue from Operations: For the full year FY26, Revenue from Operations amounted to Rs 1,87,525.92 lakh, reflecting a 12.30% YoY growth from Rs 1,66,983.16 lakh in FY25. Total Income: In Q4FY26, Total Income reached Rs 55,226.79 lakh, up by 6.22% QoQ from Rs 51,991.89 lakh in Q3FY26, and higher by 18.73% YoY compared to Rs 46,513.77 lakh in Q4FY25. Annual Total Income: For FY26, Total Income stood at Rs 1,99,534.14 lakh, an increase of 13.44% YoY against Rs 1,75,895.92 lakh in FY25. Net Profit: Net Profit for Q4FY26 was reported at Rs 6,504.10 lakh, reflecting a decline of 8.15% QoQ from Rs 7,080.89 lakh in Q3FY26, and a decrease of 29.18% YoY from Rs 9,183.42 lakh in Q4FY25. Annual Net Profit: For FY26, Net Profit stood at Rs 32,072.99 lakh, a slight drop of 5.27% YoY compared to Rs 33,855.72 lakh in FY25. Total Comprehensive Income: Total Comprehensive Income for Q4FY26 was Rs 8,993.90 lakh, and for the full year FY26, it amounted to Rs 36,721.58 lakh. Standalone Financial Highlights: Revenue from Operations: Revenue from Operations for Q4FY26 came in at Rs 44,301.49 lakh, up by 5.77% QoQ from Rs 41,886.15 lakh in Q3FY26, and growing by 5.24% YoY from Rs 42,096.94 lakh in Q4FY25. Annual Revenue from Operations: For FY26, Annual Revenue from Operations was Rs 1,66,246.48 lakh, showing an increase of 3.79% YoY against Rs 1,60,179.98 lakh in FY25. Total Income: Total Income for Q4FY26 was Rs 45,813.68 lakh, registering an increase of 2.17% QoQ against Rs 44,841.37 lakh in Q3FY26, and a 2.97% growth YoY from Rs 44,491.80 lakh in Q4FY25. Annual Total Income: For FY26, Annual Total Income stood at Rs 1,78,238.25 lakh, growing 5.37% YoY from Rs 1,69,157.22 lakh in FY25. Net Profit: Net Profit for Q4FY26 was Rs 8,062.17 lakh, increasing by 2.86% QoQ from Rs 7,838.38 lakh in Q3FY26, but declining by 6.97% YoY from Rs 8,666.02 lakh in Q4FY25. Annual Net Profit: For FY26, Net Profit was Rs 33,598.49 lakh, reflecting a marginal growth of 1.40% YoY from Rs 33,133.47 lakh in FY25. Total Comprehensive Income: Total Comprehensive Income for Q4FY26 was Rs 8,125.00 lakh, and for the full year FY26, it stood at Rs 33,621.11 lakh. Business & Segment Highlights: Dividend: The Board of Directors recommended a dividend of Rs 3.50 (70%) per Equity Share of Rs 5 each for the financial year 2025-26, subject to the approval of shareholders. Segment Performance: The company's operations fall entirely under "Medical Devices", which is considered to be the only reportable segment by the management. Therefore, overall financial results fully reflect the performance of this single segment. Fund Raising (QIP): The company successfully raised Rs 99,999.98 lakh during the previous year by issuing 53,19,148 equity shares of Rs 5 each at a premium of Rs 1,875 each (issue price of Rs 1,880 per share) to Qualified Institutional Investors on a QIP basis. Strategic Acquisitions: The Group acquired 90% economic rights in the Pendracare Group (comprising Pendracare Holdings BV and Welling Medical BV) through RISOR Holding BV. The Group also acquired 100% economic rights in Medistream SA, Switzerland (comprising Citieffe group) through its wholly owned subsidiary company Poly Medicure BV Netherlands. Resolution Plan Approval: The Hon’ble NCLT of Allahabad approved the company's resolution plan for Himalayan Mineral Water Private Limited (Target Company). An amount of Rs 3,316.00 lakh has been deposited to acquire 100% equity shareholding in the target company. Auditor Appointments: The company approved the re-appointment of M/s. PricewaterhouseCoopers Services LLP and M/s Oswal Sunil & Co. (Chartered Accountants) as Internal Auditors for FY27. Result PDF

• ટ્રેન્ડલાઇન
• 3 અઠવાડિયા 2 દિવસ પહેલાં

હેલ્થકેર સપ્લાય કંપની પોલી મેડિક્યોરએ Q3FY26 પરિણામોની જાહેરાત કરી: Q3FY25 દરમિયાન ₹ 424.2 કરોડ સામે ₹ 493.7 કરોડ, ફેરફાર 16%. ઇબીઆઇટીડીએ: Q3FY25 દરમિયાન ₹ 116.1 કરોડ સામે ₹ 119.4 કરોડ, 3% બદલો. EBITDA માર્જિન: Q3FY26 માટે 24.2%. પીબીટી: Q3FY25 દરમિયાન ₹ 113.2 કરોડ સામે ₹ 97.6 કરોડ, -14% બદલો. પીએટી: Q3FY25 દરમિયાન ₹ 85.2 કરોડ સામે ₹ 70.8 કરોડ, -17% બદલો. PAT માર્જિન: Q3FY26 માટે 13.6%. ઇપીએસ: Q3FY26 માટે ₹ 7. પરિણામની PDF

• ટ્રેન્ડલાઇન
• 4 મહિના 1 અઠવાડિયા પહેલાં

Q2FY26 પરફોર્મન્સ અને આઉટલુક પર પોલી મેડિક્યોર મેનેજમેન્ટ અને વિશ્લેષકો સાથે કૉન્ફરન્સ કૉલ. સંપૂર્ણ કમાણીની ટ્રાન્સક્રિપ્ટ સાંભળો.

• ટ્રેન્ડલાઇન
• 7 મહિના 1 અઠવાડિયા પહેલાં